- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-09-0007878

About Worels Pharma Private Limited
Data last updated:
Worels Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 09 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2020PTC146732. Its GSTIN is 36AACCW8291N1ZJ (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajeswari Pidintla and Krishna Kamal Patibandla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2 – 4 – 284 Samathapuri Colony New Nagole, Hyderabad, Telangana, India – 500035.
As per the financials filed for FY 2024, the company reported a revenue of ₹23.25 Lakh, a decline of 53% compared to the previous year. For the same year it recorded a net loss of ₹42,819 (net margin -1.8%) and EBITDA of ₹85,896 (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 39% over three years.
Worels Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0007878). For more details, the company can be reached via its website worelspharma.com.
Company details
Recognitions & Rankings of Worels Pharma
Contact details
Worels Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is worelspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address2 – 4 – 284 Samathapuri Colony New Nagole, Hyderabad, Telangana, India – 500035
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Worels Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Worels Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Worels Pharma Private Limited, buy the company report.
Financials of Worels Pharma Private Limited
FY 2025 filings availableWorels Pharma Private Limited reported revenue of ₹23.25 Lakh (down 53% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 53% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 39%. EBITDA rose 114% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹85,896 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹42,819 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 3.7% | |||
| Net Profit Margin | -1.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Worels Pharma Private Limited, buy the company report.
Board of directors of Worels Pharma Private Limited
Worels Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeswari Pidintla | Director | 09 Dec 2020 | 5 Years 10 Months | Current |
| Krishna Kamal Patibandla | Director | 09 Dec 2020 | 5 Years 10 Months | Current |
Peer comparison
Worels Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Galaxy SCM Private Limited | ₹23.25 Lakh (FY 2021) | 127.0% | Pune, Maharashtra, India | |||
| H N Trade International Limited | ₹23.25 Lakh (FY 2019) | 1268.0% | Uttar Pradesh, India | |||
| Buniyadi Oil Seeds Producer Company Limited | ₹23.25 Lakh (FY 2024) | 369.0% | Palitana, Gujarat, India | |||
| Prosperity Fashion Private Limited | ₹23.25 Lakh (FY 2020) | -21.0% | Gorakhpur, Uttar Pradesh, India | |||
| G. A. Exports Private Limited | ₹23.25 Lakh (FY 2016) | 57.0% | New Delhi, Delhi, India | |||
| Worels Pharma Private Limitedthis company | ₹23.25 Lakh (FY 2024) | -₹42,819 | -1.8% | -53.0% | Hyderabad, Telangana, India | |
| Kar Auto Private Limited | ₹23.24 Lakh (FY 2025) | 6.0% | Ddy, Telangana, India | |||
| Velisca Healthcare Private Limited | ₹23.23 Lakh (FY 2022) | 165.0% | Mumbai, Maharashtra, India | |||
| Maxaroma Private Limited | ₹23.23 Lakh (FY 2025) | -28.0% | Punjab, India | |||
| Magnifiq Pharma Private Limited | ₹23.22 Lakh (FY 2025) | 26.0% | Hyderabad, Telangana, India | |||
| Sumangal Collection Private Limited | ₹23.22 Lakh (FY 2023) | 21.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Worels Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Worels Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Worels Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Worels Pharma Private Limited has 1 active EPFO establishment as of Mar 30, 2024.
GST
Worels Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCW8291N1ZJ | Telangana | Active | 03 Jan 2021 |
To see the full GST registrations and return filing status of Worels Pharma Private Limited, buy the company report.
Recent activity
Worels Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Krishna Kamal Patibandla was appointed as Director on 09 Dec 2020.
Frequently asked questions
Worels Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in specialty, within the trading industry. It was incorporated on 09 December 2020 (6+ years old) and is registered under CIN U51909TG2020PTC146732.
Worels Pharma has 2 current directors:
- Rajeswari Pidintla - Director
- Krishna Kamal Patibandla - Director
The latest financial statements of Worels Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Worels Pharma is 36AACCW8291N1ZJ, registered in Telangana.
The CIN (Corporate Identification Number) of Worels Pharma is U51909TG2020PTC146732. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Worels Pharma was incorporated on 09 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Worels Pharma by revenue are Galaxy SCM Private Limited, H N Trade International Limited, Buniyadi Oil Seeds Producer Company Limited, Prosperity Fashion Private Limited, G. A. Exports Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Krishna Kamal Patibandla was appointed as Director on 09 Dec 2020. Rajeswari Pidintla was appointed as Director on 09 Dec 2020.
Yes, Worels Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0007878).
Worels Pharma can be reached through the website worelspharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Worels Pharma is at 2 – 4 – 284 Samathapuri Colony New Nagole, Hyderabad, Telangana, India – 500035.